Scientist Arjan Griffioen leads cancer treatment innovation with lab and startup (Amsterdam UMC)
Could an innovative cancer treatment be used as a preventative vaccine? Arjan Griffioen and his team are determined to find out. These scientists have been developing proteins that specifically target cancer cells in the blood, leaving healthy tissue untouched. Every step of this journey—from vision to execution—has relied on the team’s dedication, as well as essential funding and investment. Spoiler alert: bringing the new treatment to market is not done overnight! Curious about the steps necessary? Watch the video to hear the full story by Arjan Griffioen and Else Huijbers.
Explore other Stories:
Putting your research results to work in clinical practice
Cancer Center Amsterdam has a dedicated IXA alliance office to assist oncology researchers in creating value from their expertise and discoveries
COMCRIM – Jill Coster van Voorhout PhD, associate professor
COMCRIM: COMbatting CRIMes that undermine the rule of law in a smart and comprehensive manner, in a financial public-private partnership and through artificial intelligence – with a focus on human trafficking, money laundering and corruption Contactpersoon: Mw. mr. dr. drs. J.E.B. (Jill) Coster van Voorhout PhD, associate professor.
Stories of Physics2Market Fund
The Physics2Market fund offered researchers the opportunity to take physics research from lab to society. For example, by building a prototype or proof-of-concept study, collaborations with companies emerged. Raoul Frese – assistant professor at the Faculty of Science, Biophysics Photosynthesis/Energy at Vrije Universiteit Amsterdam – received the last Physics2Market subsidy to further develop material to […]